Please see below to view details for this session presenter

Tim Kutzkey, PhD

Partner, The Column Group

Dr. Kutzkey is a Partner with The Column Group (TCG), a San Francisco-based venture capital firm focused on building the next generation of biotechnology companies. For the past 5 years he has contributed to the conception, formation, and management of 7 TCG portfolio companies. He currently serves as acting Chief Executive Officer of Peloton Therapeutics. Dr. Kutzkey is also a member of the board of directors for Carmot Therapeutics, Cyterix Pharmaceuticals, and Nurix, and is a board observer at Igenica and Immune Design. Prior to TCG, he was a scientist at KAI Pharmaceuticals, where he focused on the discovery and development of selective protein kinase C inhibitors. Dr. Kutzkey completed his PhD and postdoctoral work in the lab of Dr. Robert Tjian at the University of California, Berkeley. He was previously educated at Stanford University.